Skip to main content
Top
Published in: International Journal of Legal Medicine 2/2018

01-03-2018 | Original Article

Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?

Authors: M. Falk, R. Huhn, F. Behmenburg, St Ritz-Timme, F. Mayer

Published in: International Journal of Legal Medicine | Issue 2/2018

Login to get access

Abstract

Myocardial infarctions go along with biomechanical stress, i.e. stretching of muscle fibres, and the expression of certain marker molecules. We tested if two of those markers, endothelin-1 (ET-1) and growth differentiation factor 15 (GDF-15), can be used as immunohistochemical markers for myocardial ischaemia/infarctions. The study included experiments with an animal model, the isolated perfused Langendorff heart, as well as the investigation of human tissue samples drawn during autopsies. The overall picture of our results showed that GDF-15 is very sensitive and expressed very fast, not only as a consequence of ischaemia/infarctions, but also under other circumstances. Even an expression only caused by agony had to be discussed. ET-1, on the other hand, was less sensitive but only positive in those human cases with ischaemia/infarction that also showed typical alterations in conventional histology. Therefore, both markers did not proof to be a suitable diagnostic tool for myocardial infarctions. However, positive staining for ET-1 was also seen in rats’ hearts that suffered from arrhythmias after electric shock and in the myocardium of the right ventricle in human control cases in which a right heart failure has to be discussed. Thus, especially ET-1 should be subject of further studies that focus on these pathologies.
Literature
1.
go back to reference Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRefPubMed Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRefPubMed
3.
go back to reference Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292CrossRefPubMed Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292CrossRefPubMed
7.
go back to reference Cummings PM, Trelka DP, Springer KM (2011) Atlas of forensic histopathology. Cambridge University Press, Cambridge; New YorkCrossRef Cummings PM, Trelka DP, Springer KM (2011) Atlas of forensic histopathology. Cambridge University Press, Cambridge; New YorkCrossRef
8.
go back to reference Thomsen H, Schulz A, Bhakdi S (1990) Immunhistochemische C5b-9-komplement-komplex-darstellung in frühstadien der herzmuskelnekrosen am paraffinschnitt. Int J Legal Med 103:199–206CrossRef Thomsen H, Schulz A, Bhakdi S (1990) Immunhistochemische C5b-9-komplement-komplex-darstellung in frühstadien der herzmuskelnekrosen am paraffinschnitt. Int J Legal Med 103:199–206CrossRef
9.
go back to reference Bi H, Yang Y, Huang J et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84CrossRefPubMedPubMedCentral Bi H, Yang Y, Huang J et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84CrossRefPubMedPubMedCentral
12.
go back to reference Bootcov MR, Bauskin AR, Valenzuela SM et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94:11514–11519CrossRefPubMedPubMedCentral Bootcov MR, Bauskin AR, Valenzuela SM et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94:11514–11519CrossRefPubMedPubMedCentral
13.
go back to reference Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700CrossRefPubMed Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700CrossRefPubMed
14.
go back to reference Fairlie WD, Moore AG, Bauskin AR et al (1999) MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65:2–5CrossRefPubMed Fairlie WD, Moore AG, Bauskin AR et al (1999) MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65:2–5CrossRefPubMed
15.
go back to reference Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol Cell Biol 20:3742–3751CrossRefPubMedPubMedCentral Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol Cell Biol 20:3742–3751CrossRefPubMedPubMedCentral
19.
go back to reference Masaki T, Yanagisawa M, Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391–421CrossRefPubMed Masaki T, Yanagisawa M, Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391–421CrossRefPubMed
21.
go back to reference Loennechen JP, Stoylen A, Beisvag V et al (2001) Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Phys 280:H2902–H2910 Loennechen JP, Stoylen A, Beisvag V et al (2001) Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Phys 280:H2902–H2910
22.
go back to reference Oie E, Vinge LE, Tønnessen T et al (1997) Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Phys 273:H1727–H1736 Oie E, Vinge LE, Tønnessen T et al (1997) Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Phys 273:H1727–H1736
23.
go back to reference Tønnessen T, Lunde PK, Giaid A et al (1998) Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide. Cardiovasc Res 39:633–643CrossRefPubMed Tønnessen T, Lunde PK, Giaid A et al (1998) Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide. Cardiovasc Res 39:633–643CrossRefPubMed
24.
go back to reference Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57PubMedPubMedCentral Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57PubMedPubMedCentral
25.
go back to reference Ono K, Matsumori A, Shioi T et al (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149–156CrossRefPubMed Ono K, Matsumori A, Shioi T et al (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149–156CrossRefPubMed
26.
go back to reference Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 275:H250–H258CrossRef Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 275:H250–H258CrossRef
28.
go back to reference Sütsch G, Kiowski W, Yan XW et al (1998) Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98:2262–2268CrossRefPubMed Sütsch G, Kiowski W, Yan XW et al (1998) Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98:2262–2268CrossRefPubMed
29.
go back to reference Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225–228CrossRefPubMed Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225–228CrossRefPubMed
30.
go back to reference Takuwa N, Takuwa Y, Yanagisawa M et al (1989) A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264:7856–7861PubMed Takuwa N, Takuwa Y, Yanagisawa M et al (1989) A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264:7856–7861PubMed
31.
go back to reference Ito H, Hirata Y, Hiroe M et al (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209–215CrossRefPubMed Ito H, Hirata Y, Hiroe M et al (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209–215CrossRefPubMed
32.
go back to reference Molenaar P, O’reilly G, Sharkey A et al (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538CrossRefPubMed Molenaar P, O’reilly G, Sharkey A et al (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538CrossRefPubMed
Metadata
Title
Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?
Authors
M. Falk
R. Huhn
F. Behmenburg
St Ritz-Timme
F. Mayer
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 2/2018
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1726-z

Other articles of this Issue 2/2018

International Journal of Legal Medicine 2/2018 Go to the issue